Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Documents (278)

Showing 12 of 278 View All
Showing 17 of 24 pages

Technical briefing Private sector engagement approach pdf

www.gavi.org
Gavi?s 2016 - 2020 private
sector engagement approach
SCALING INNOVATION FOR IMPACT
Gavi Board technical briefing session
21 June 2016 | Geneva, Switzerland
Reaching further, together
A HISTORY OF CREATING SHARED VALUE
PUBLIC PRIVATE PARTNERSHIP WITH VACCINE MANUFACTURERS
VACCINE PRICE
Total cost to immunise
a child with pentavalent, pneumococcal
and rotavirus vaccines (US$)
DIVERSIFICATION
Number of vaccine manufacturers
*Future targets are not publicised to avoid setting a minimum price .
Source: UNICEF Supply Division, 2016.
$35 $33
$23 $22 $22
$20
2010
Baseline
2011 2012 2013 2014 2015
5
2001 2015
16
Manufacturers
in 11 countries
Manufacturers
in 5 countries
SHIFTING MINDSET
Of vaccine manufacturers by
pooling country demand

00b Agenda pdf

Board -2016 -Mtg -1-Doc 00b
`



G avi Alliance Board Meeting
22 -23 June 2016
Starling Hotel, Geneva, Switzerland

Monday 20 and Tuesday 21 June : Pre -Board meetings
Wednesday 22 June : 0 8.30 -18. 00 (Board meeting Day One)
Thursday 23 June : 0 9.00 -16.45 (Board meeting Day Two)
Quorum: 14


Agenda



Pre -Board Meetings ? Monday, 20 June 2016
Item Subject Room Schedule

? IFFIm Donors? workshop Leysin 10.00 -15.30
? AMC Stakeholders? meeting Leysin 16. 15 -18. 15


Pre -Board Meetings ? Tuesday , 21 June 2016
Item Subject Room Schedule

? Technical Briefing Session s
o HPV Demonstration Projects ? Lessons Learnt
Break
o Private Sector Strategy
Break
o Finance
Nendaz 08.30 -13.00
08. 30 -10.00
10.00 -10.15
10.15 -11. 30
11. 30 -11.45
11.45 -13.00
? IFFIm Board Meeting Villars 13.00 -16.45
? Developi ng Countries Board members meeting Montana 13.00 -15. 00
? Governance Committee meeting Arosa 15. 00-17.00
? Board Meeting: Closed session for Board members
and Alternate Board members
Montana 17. 30 -19.00
? Gavi Donors? meeting Nendaz 19.30 -21.30
? Unaffiliat ed Board members dinner 19.30

03 2016 2020 Strategy Implementation and progress pdf

Gavi?s 2016 ? 2020 strategic framework
22 June 2016
Gavi 2000 -2015
? Support for 3 vaccines
? Immunisation services support,
injection safety
2000 2005 2006 2010 2011 2015
? 4 vaccines added, incl
rotavirus, pneumococcal
? Health system strengthening
programme started
? Innovative finance
? First co -financing policy
? 12 vaccines in Gavi portfolio
? Acceleration of vaccine introductions
? Proactive market shaping
? First graduation policy
90m children immunised
200 million
children immunised
250 million
children immunised
Gavi 1.0
Gavi 2.0
Gavi 3.0

Subscribe to our newsletter